Abcellera Biologics Inc (ABCL) — Strategic Asset Allocation Index
Abcellera Biologics Inc (ABCL) has a Strategic Asset Allocation Index of 7.0% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $65.31 Million) total $65.31 Million, measured against net assets of $938.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Abcellera Biologics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Abcellera Biologics Inc Strategic Asset Allocation Index (2018–2025)
This chart shows how Abcellera Biologics Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the index stands at 7.0%, representing strategic assets of $65.31 Million against net assets of $938.08 Million USD. See ABCL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Abcellera Biologics Inc (2018–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Abcellera Biologics Inc from 2018 to 2025, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Abcellera Biologics Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.5% | $62.58 Million | $- | $62.58 Million | $966.90 Million | ▼ -1.3 pp |
| 2024 | 7.8% | $82.30 Million | $- | $82.30 Million | $1.06 Billion | ▲ +2.1 pp |
| 2023 | 5.7% | $65.94 Million | $- | $65.94 Million | $1.15 Billion | ▼ -17.8 pp |
| 2022 | 23.5% | $289.78 Million | $217.25 Million | $72.52 Million | $1.23 Billion | ▲ +7.7 pp |
| 2021 | 15.8% | $161.93 Million | $111.62 Million | $50.31 Million | $1.03 Billion | ▲ +11.3 pp |
| 2020 | 4.5% | $37.17 Million | $17.92 Million | $19.25 Million | $830.51 Million | ▼ -78.2 pp |
| 2019 | 82.7% | $8.48 Million | $8.48 Million | $- | $10.25 Million | ▲ +28.2 pp |
| 2018 | 54.5% | $6.33 Million | $6.33 Million | $- | $11.61 Million | — |